237 related articles for article (PubMed ID: 29511175)
1. Low population serum microneutralization antibody titer against the predominating influenza A(H3N2) N121K virus during the severe influenza summer peak of Hong Kong in 2017.
Zhu H; Lee ACY; Li C; Mak WWN; Chen YY; Chan KH; Zhang AJX; Fung WF; Zhang RQ; Fung YF; Poon RWS; Lam JY; Tam S; Hung IFN; Chen H; Yuen KY; To KKW
Emerg Microbes Infect; 2018 Mar; 7(1):23. PubMed ID: 29511175
[TBL] [Abstract][Full Text] [Related]
2. Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.
Levine MZ; Martin ET; Petrie JG; Lauring AS; Holiday C; Jefferson S; Fitzsimmons WJ; Johnson E; Ferdinands JM; Monto AS
J Infect Dis; 2019 May; 219(12):1904-1912. PubMed ID: 30721982
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination.
Levine MZ; Martin JM; Gross FL; Jefferson S; Cole KS; Archibald CA; Nowalk MP; Susick M; Moehling K; Spencer S; Chung JR; Flannery B; Zimmerman RK
Clin Vaccine Immunol; 2016 Oct; 23(10):831-839. PubMed ID: 27558294
[TBL] [Abstract][Full Text] [Related]
4. Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season - a serological study using retrospective samples collected in Hong Kong.
Liang W; Lv H; Chen C; Sun Y; Hui DS; Mok CKP
Int J Infect Dis; 2023 Oct; 135():1-4. PubMed ID: 37481108
[TBL] [Abstract][Full Text] [Related]
5. Differential Antibody Recognition of H3N2 Vaccine and Seasonal Influenza Virus Strains Based on Age, Vaccine Status, and Sex in the 2017-2018 Season.
Ursin RL; Liu H; Powell HR; Westerbeck JW; Shaw-Saliba K; Sylvia KE; Fenstermacher KJ; Mehoke T; Thielen P; Rothman RE; Pekosz A; Klein SL
J Infect Dis; 2020 Sep; 222(8):1371-1382. PubMed ID: 32496543
[TBL] [Abstract][Full Text] [Related]
6. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunogenicity between candidate influenza A(H3N2) virus vaccine strains in Japan: A randomized controlled trial using a monovalent vaccine of A/Saitama/103/2014 (CEXP-002) and A/Hong Kong/4801/2014 (X-263).
Kase T; Inoue M; Morikawa S; Kumashiro H; Hiroi S; Nakata K; Ito K; Ishibashi M; Tsuru T; Irie S; Maeda A; Ohfuji S; Fukushima W; Hirota Y
Vaccine; 2020 Sep; 38(42):6524-6532. PubMed ID: 32873406
[TBL] [Abstract][Full Text] [Related]
8. Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons.
Hiroi S; Morikawa S; Nakata K; Maeda A; Kanno T; Irie S; Ohfuji S; Hirota Y; Kase T
Hum Vaccin Immunother; 2015; 11(2):386-90. PubMed ID: 25692378
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
Kishida N; Fujisaki S; Yokoyama M; Sato H; Saito R; Ikematsu H; Xu H; Takashita E; Tashiro M; Takao S; Yano T; Suga T; Kawakami C; Yamamoto M; Kajiyama K; Saito H; Shimada S; Watanabe S; Aoki S; Taira K; Kon M; Lin JH; Odagiri T
Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
[TBL] [Abstract][Full Text] [Related]
10. The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine.
Petrie JG; Malosh RE; Cheng CK; Ohmit SE; Martin ET; Johnson E; Truscon R; Eichelberger MC; Gubareva LV; Fry AM; Monto AS
Clin Infect Dis; 2017 Oct; 65(10):1644-1651. PubMed ID: 29020179
[TBL] [Abstract][Full Text] [Related]
11. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011.
Ann J; Papenburg J; Bouhy X; Rhéaume C; Hamelin MÈ; Boivin G
J Clin Virol; 2012 Jan; 53(1):88-92. PubMed ID: 22036039
[TBL] [Abstract][Full Text] [Related]
12. Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera.
Xie H; Li L; Ye Z; Li X; Plant EP; Zoueva O; Zhao Y; Jing X; Lin Z; Kawano T; Chiang MJ; Finch CL; Kosikova M; Zhang A; Zhu Y; Wan XF
Clin Infect Dis; 2017 Jul; 65(2):259-267. PubMed ID: 28369230
[TBL] [Abstract][Full Text] [Related]
13. Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains.
Chen LL; Wu WL; Chan WM; Fong CHY; Ng ACK; Ip JD; Lu L; Dissanayake TK; Ding X; Cai JP; Zhang AJX; Tam S; Hung IFN; Chan KH; Yuen KY; To KKW
Epidemiol Infect; 2019 Sep; 147():e279. PubMed ID: 31556360
[TBL] [Abstract][Full Text] [Related]
14. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
[TBL] [Abstract][Full Text] [Related]
15. Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.
Trebbien R; Fischer TK; Krause TG; Nielsen L; Nielsen XC; Weinreich LS; Lis-Tønder J; Skov MN; Christiansen CB; Emborg HD
J Clin Virol; 2017 Sep; 94():1-7. PubMed ID: 28697450
[TBL] [Abstract][Full Text] [Related]
16. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial.
Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY
Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482
[TBL] [Abstract][Full Text] [Related]
17. Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong.
Tam YH; Valkenburg SA; Perera RAPM; Wong JHF; Fang VJ; Ng TWY; Kwong ASK; Tsui WWS; Ip DKM; Poon LLM; Chau CKV; Barr IG; Peiris JSM; Cowling BJ
Clin Infect Dis; 2018 Mar; 66(6):904-912. PubMed ID: 29069368
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinations.
Zhang T; Han Y; Huang W; Wei H; Zhao Y; Shu L; Guo Y; Ye B; Zhou J; Liu J
J Med Virol; 2024 Jun; 96(6):e29743. PubMed ID: 38884419
[TBL] [Abstract][Full Text] [Related]
19. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.
Skowronski DM; Janjua NZ; De Serres G; Sabaiduc S; Eshaghi A; Dickinson JA; Fonseca K; Winter AL; Gubbay JB; Krajden M; Petric M; Charest H; Bastien N; Kwindt TL; Mahmud SM; Van Caeseele P; Li Y
PLoS One; 2014; 9(3):e92153. PubMed ID: 24667168
[TBL] [Abstract][Full Text] [Related]
20. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
Broecker F; Liu STH; Sun W; Krammer F; Simon V; Palese P
J Virol; 2018 Oct; 92(20):. PubMed ID: 30045991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
